Coping With ‘Financial Toxicity’

Multiple myeloma, a type of cancer affecting the bone marrow, will be diagnosed in an estimated 27,000 Americans this year. Advances in research are expanding treatment options and improving outcomes in multiple myeloma patients, but these new medications often come with a higher price point. The expensive treatments for this disease have triggered alarming developments:…

World Hepatitis Day

One of the key messages of today July 28th, World Hepatitis Day, is simply this: hepatitis C is a preventable and treatable disease. The World Health Organization created World Hepatitis Day to raise awareness about the massive number of people already infected with one of several hepatitis viruses, including the hepatitis C, and how anyone…

Biosimilars: Close to the Real Thing

The issue of “biosimilar” medications has been under debate for years. Now, the U.S. Food and Drug Administration (FDA) is on the cusp of approving the first biosimilar. In case you don’t know, biosimilars are less expensive versions of already approved biological medications used for cancer, autoimmune, and other diseases. Biologic medications are typically large…

Even Successful Treatment Can Come With Unintended Effects

Kimberly M. Hicks, Pharm.D., M.H.A., Clinical Pharmacy Specialist at BioPlus Specialty Pharmacy   The relationship between breast cancer and a woman’s wallet is a good news/bad news situation. The good news is that women who survive breast cancer treatment are, well, alive. The bad news is that a significant number of these women deal with…

A Special Touch

Brittany Trane knew that she’d really found the right place to work, soon after starting at BioPlus Specialty Pharmacy. One of the first patients she interacted with was Craig*, a patient with multiple sclerosis, who had been prescribed a new medication, called Rebif®. Rebif is used in the relapsing form of multiple sclerosis, to decrease…

Patient Assistance Lends a Hand

Specialty pharmacy continues to see annual increases in terms of U.S. spending on prescriptions for the treatment of complex or chronic diseases. URAC estimates that specialty drugs account for more than $50 billion of U.S. drug expenditures and comprises nearly 20 percent of the total pharmaceutical revenue. Specialty pharmacy is expected to make up approximately…

Expensive Out-of-Pocket Costs: The Latest Treatment Side Effect?

High health care costs leading to financial strain should be considered a side effect of treating a disease for some patients, posits Peter Ubel, M.D., Professor at Duke University, and his colleagues in a provocative new article in the New England Journal of Medicine. Most physicians speak openly with patients about a new chemotherapy medication…

Saving Health Care Dollars, One Injection at a Time

As health care costs continue to rise, cost containment is on everyone’s mind. Cutting services and benefits might save money, but it’s not a very satisfying way to serve patients. Easily implementable health care practices and policies that reduce costs while preserving high-level care make much more sense. Self-administration of injectable medications fits the bill…

Safety Net: Patient Assistance Programs

Guest Blog: Barbara Weller, Vice President of Finance When a loved one is sick with a life-threatening illness, knowing that there are treatments available is comforting. Life-saving treatments priced out of the budget however, is less than comforting. Many chronic and life-threatening diseases require medications costing thousands of dollars. Most families find that their insurance…